Creative Biolabs-Immuno-oncology

Anti-CCL2 (clone 1G.2E.1G) SynExpress C-G-AR-K Modified CD8+ T cells (CAT#: ITS-1224-CR304)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCL2 (clone 1G.2E.1G). We employs the AAV (CMV-GFP-AR-KpnI) vector components and the SynExpress system of the Multiple base pair Insertion/Negative feedback for a robust and sustained response against cancers.
Host
human
Target
CCL2
Clone
1G.2E.1G
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
AR
Insertion Sites
KpnI
Gene Modification
Insertion
Modification Domain
Multiple base pair
Carrier Type
AAV
Transformation Accuracy
0.94
Cell Culture
Microcarrier Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving